Provided by Tiger Trade Technology Pte. Ltd.

Renaissance Technologies Holdings

2,983.90
+26.690.90%
Number of Gainers:58
Number of Losers:37
Number of Flat:1
PE:- -
High:2,998.52
Open:2,956.72
Low:2,956.72
Close:2,957.21
Volume:614.86M
Turnover:134.46B
Market Cap:32.56T
Float Cap:30.60T

Loading ...

Qualcomm Stock (QCOM) Rises Even as Barclays Says to Sell Despite $60B Amazon Chip Deal

TIPRANKS
·
Sep 09

Fortum Publishes Transcript of Google Partner Presentation

Reuters
·
Sep 09

Taiwan August Exports Hit Record Value on Solid AI Demand

Reuters
·
Sep 09

European Shares Slip as Brent Breaches $100

Reuters
·
Sep 09

Zoom Sees FY Net Y400.00m

Dow Jones
·
Sep 09

Decoding Apple's Foldable Naming Puzzle: Duo, Ultra, or Fold?

Deep News
·
Sep 09

Market Chatter: OpenAI, Samsung Deepen Partnership on Chipmaking, Operations

MT Newswires Live
·
Sep 09

Nio's William Li urges focus on core business for next 3 years, teases major new models for 2027

CnEVPost
·
Sep 09

Google to Invest $15 Billion in AI Infrastructure and Buy Nuclear Power in Finland

Reuters
·
Sep 09

Novartis's Stock Selloff Looks Overdone

Dow Jones
·
Sep 09

Market Chatter: UnitedHealth Sells Stake in Florida Optum Health Operations to TPG

MT Newswires Live
·
Sep 09

DOJ Reportedly Expands Antitrust Review of Fox-Roku Acquisition

Deep News
·
Sep 09

Google Plans €13 Billion AI Data Center Build in Finland, Marking the Firm’s ‘Largest Single Investment in Europe’

TIPRANKS
·
Sep 09

NIO Founder Predicts EVs Could Dominate 90% of New Car Sales by 2030, With Pure Electric Leading the Charge

Deep News
·
Sep 09

Celonis, Uniper Collaborate with Microsoft to Deploy HR Hiring AI Agent

Reuters
·
Sep 09

OpenAI Taps Samsung For Chips

Tech News Roundup
·
Sep 09

Santander Launches USD 2 Million 3-Year Equity-Linked Notes Offering

Reuters
·
Sep 09

Daimler Truck Hands over First 27 eActros 600 Electric Trucks to Amazon in Germany Under 200-Plus Order

Reuters
·
Sep 09

CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds

Reuters
·
Sep 09

Novartis Faces Sales Hole in Early 2030s After Trial Setback

Dow Jones
·
Sep 09